Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Shanghai Mabgeek Biotech.Co.Ltd

Clinicaltrial registered16 Nov 2026

Shanghai Mabgeek Biotech.Co.Ltd

16 Nov 2026: Trial registered · MG-K10 in Pediatric Atopic Dermatitis (6-12 Years). Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
16 Nov 2026
Title
MG-K10 in Pediatric Atopic Dermatitis (6-12 Years)
Conditions
Atopic Dermatitis
Phase
Phase 1, Phase 2
Study Type
Interventional
Status
Not Yet Recruiting
Countries
China
Country
China
Reference
NCT07938606
Location
China
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Shanghai Mabgeek Biotech.Co.Ltd

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Shanghai Mabgeek Biotech.Co.Ltd in our registers.

More from China

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.